The Study to YD312 Tablet in Patients With Diabetic Macular Edema
Status:
Active, not recruiting
Trial end date:
2020-03-20
Target enrollment:
Participant gender:
Summary
This study objectives is to evaluate the efficacy of YD312 to improve visual acuity in
patients with diabetic macular edema (DME) compared to placebo and determine optimal dose of
phase 2b study.